Imprivata ID

Imprivata ID is a secure authentication mobile app designed to optimize clinical workflows for healthcare professionals. Ideal for electronic prescribing of controlled substances (EPCS) and remote network access, Imprivata ID simplifies authentication processes.

Key features include Hands-Free Authentication, a groundbreaking solution meeting DEA two-factor authentication mandates for EPCS. This eliminates manual code entry, wirelessly verifying one-time passwords from a user's mobile device, even if locked or in a pocket. For remote network access, swift and convenient push notifications provide effortless identity verification.

To implement Imprivata ID, healthcare organizations require licenses for Imprivata Confirm ID and Hands-Free Authentication (if utilizing that feature). Download the app today for a secure and efficient authentication experience. Learn more at https://www.imprivata.com/imprivata-confirm-id.

Key Features:

• Enhanced Security: Imprivata ID provides robust authentication, improving clinical workflows, especially for EPCS and remote access.
• Hands-Free EPCS Authentication: Revolutionizes authentication by eliminating manual code input. One-time passwords are wirelessly retrieved and verified.
• Rapid Push Notifications: Facilitates quick and easy remote network access verification via push notifications. Users can approve access directly from their locked device.
• Unmatched Speed and Ease: Hands-Free Authentication minimizes workflow disruption.
• DEA Compliance: Meets DEA's two-factor authentication requirements for EPCS.
• Licensing: Requires Imprivata Confirm ID and Hands-Free Authentication licenses (for the Hands-Free feature).

In summary:

Imprivata ID is a powerful, secure authentication app enhancing clinical workflows. Its hands-free authentication, fast push notifications, and DEA compliance deliver exceptional speed, convenience, and security. Healthcare organizations can significantly improve remote network access and EPCS with Imprivata ID. Licensing is required; visit the link above for details.